Trial Profile
Evaluating Nulojix Long-Term Safety in Transplant.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jun 2022
Price :
$35
*
At a glance
- Drugs Belatacept (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Adverse reactions
- Acronyms ENLIST
- Sponsors Bristol-Myers Squibb
- 02 Jun 2022 Status changed from active, no longer recruiting to completed.
- 03 Jun 2020 Results presented at the 2020 American Transplant Congress.
- 09 May 2017 Status changed from recruiting to active, no longer recruiting.